For people with overweight or obesity and pre-existing cardiovascular disease (CVD), taking semaglutide for three years resulted in 20% fewer heart attacks, strokes, and deaths, compared to those taking a placebo, according to the new study
History of Gastroparesis or Pancreatitis Both medications may worsen these gastrointestinal conditions and should not be used by individuals with a history of severe gastroparesis or pancreatitis
If the solution has become noticeably more yellow, brown, or any color other than clear-to-faintly-yellow, degradation has progressed significantly
Automated analysis of semaglutide access, c-Fos activity, GLP-1R distribution, and brain connectivity revealed that activation may involve meal termination controlled by neurons in the lateral parabrachial nucleus